Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-28

Clinical Trial Update: Mirvaso® Utilisation and Patient Satisfaction Evaluation (MUSE)

View source ↗

Summary

Clinical trial update evaluating Mirvaso utilization and patient satisfaction for rosacea has completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mirvaso (brimonidine tartrate)

Snippet

Sponsor: Galderma R&D | Conditions: Rosacea | Status: COMPLETED | Results posted: 2021-05-28